On the other hand, a conflicting recent study also performed using Tregs obtained from peripheral blood, shows that there is no significant difference between the suppressive effects of FoxP3+ Tregs on certain cytokines and the proliferation of effector T cells, between Tregs obtained from healthy individuals and from RA patients [37]. The gene discussed is FOXP3; the disease is rheumatoid arthritis.